MedPath

Effects of Silymarin (Milk thistle fruit extract) on liver fibrosis in Nonalcoholic Fatty Liver Disease

Phase 2
Recruiting
Conditions
on alcoholic fatty liver disease
Registration Number
SLCTR/2017/016
Lead Sponsor
Department of Hepatology Bangabandhu Sheikh Mujib Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Fatty liver in ultrasonography of hepatobilliary system

Exclusion Criteria

1.Co-infection with Hepatitis B Virus (HBV) or Hepatitis C Virus (HCV)
2.History of significant alcoholism

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Degree of hepatic fibrosis as determined by <br>1. AST to Platelet Ratio Index <br>2. Fibroscan of liver<br> [Six months from commencing the treatment]<br>
Secondary Outcome Measures
NameTimeMethod
SGOT/SGPT ratio [One year]<br>
© Copyright 2025. All Rights Reserved by MedPath